Leading expert in non-malignant hematology, Dr. Aric Parnes, MD, explains his clinical and research focus on complex blood disorders. He treats patients with hemophilia, various anemias, and thrombotic conditions. Dr. Parnes also specializes in myelodysplastic syndromes and myeloproliferative diseases. His work is based at prestigious Harvard Medical School-affiliated institutions in Boston.
More from Diagnostic Detectives Network
Understanding Non-Malignant Hematology: Key Blood Disorders and Treatments
Jump To Section
- Expert Background and Medical Training
- Clinical Focus in Hematology
- Research Interests in Blood Disorders
- Hemophilia Treatment Advances
- Thrombosis and Blood Clot Management
- Full Transcript
Expert Background and Medical Training
Dr. Aric Parnes, MD, brings extensive international medical training to his hematology practice. He earned his medical degree from Trinity College in Dublin, Ireland, providing a broad foundation in medicine. Dr. Parnes completed his internal medicine residency at Dartmouth-Hitchcock Medical Center, honing his diagnostic skills. His specialized training includes fellowships in hematology and oncology at Yale New Haven Medical Center. Dr. Parnes further refined his expertise with an additional hematology fellowship at Dana-Farber Cancer Institute.
Clinical Focus in Hematology
Dr. Aric Parnes, MD, maintains a robust clinical practice focused on non-malignant blood disorders. He serves as a Staff Hematologist at both Brigham and Women's Hospital and Dana-Farber Cancer Institute. This dual appointment allows Dr. Parnes to treat a wide spectrum of hematologic conditions. His clinical work encompasses both common and rare blood disorders that affect patient quality of life. Dr. Anton Titov, MD, highlights how this expertise benefits patients seeking specialized care for complex hematological issues.
Research Interests in Blood Disorders
Research forms a critical component of Dr. Aric Parnes, MD' professional work in hematology. His investigations span several key areas within non-malignant hematology, contributing to advancing treatment options. Dr. Parnes conducts research on myelodysplastic syndrome, a condition affecting blood cell production. He also studies myeloproliferative diseases, where bone marrow produces too many blood cells. This research commitment ensures Dr. Parnes remains at the forefront of emerging treatments for his patients.
Hemophilia Treatment Advances
Dr. Aric Parnes, MD, possesses specialized expertise in hemophilia management and treatment innovation. Hemophilia represents a complex bleeding disorder requiring meticulous care coordination. Dr. Parnes works with patients to develop comprehensive treatment plans that address both acute bleeding episodes and long-term joint health. His research in this area contributes to better understanding of factor replacement therapies and emerging genetic treatments. Dr. Anton Titov, MD, notes that such specialized knowledge is crucial for patients with rare bleeding disorders.
Thrombosis and Blood Clot Management
Thrombosis management constitutes another essential aspect of Dr. Parnes' hematology practice. Thrombosis refers to the dangerous formation of blood clots within blood vessels, which can cause life-threatening complications. Dr. Aric Parnes, MD, treats thrombosis occurring in various disease states and pathological conditions. His approach combines anticoagulant medications with personalized risk assessment for each patient. This comprehensive management strategy helps prevent recurrent clots while minimizing bleeding risks associated with treatment.
Full Transcript
Dr. Anton Titov, MD: Greetings from Boston! Today we are with Dr. Aric Parnes, MD. He is Assistant Professor at Harvard Medical School and a Staff Hematologist at Brigham and Women's Hospital in Boston and Dana-Farber Cancer Institute, also in Boston.
Dr. Parnes received his MD from Trinity College in Dublin, Ireland. He did his residency in Internal Medicine at Dartmouth-Hitchcock Medical Center in New Hampshire. He did fellowship in Hematology and Oncology at Yale New Haven Medical Center in Connecticut. He did another fellowship in Hematology at Dana-Farber Cancer Institute in Boston.
Clinical and research interests of Dr. Parnes are in non-malignant hematology. Dr. Aric Parnes, MD, does research and clinical work in hemophilia, anemias, myelodysplastic syndrome, myeloproliferative disease and in thrombosis.
It is a formation of blood clots in many diseases and pathologic states in the body. Dr. Parnes, thank you and welcome!
Dr. Aric Parnes, MD: Thank you.